Syed Alam, MD in Bakersfield, CA - Medicare Pulmonary Disease

Syed Alam, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Bakersfield, California. He graduated from medical school in 1989 and has 35 years of diverse experience with area of expertise as Pulmonary Disease. He is a member of the group practice Atlas Urgent Care Corporation and his current practice location is 2901 Sillect Ave, Suite 202, Bakersfield, California. You can reach out to his office (for appointments etc.) via phone at (661) 324-7300.

Syed Alam is licensed to practice in California (license number A53309) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1073541512.

Contact Information

	Syed Alam, MD
	2901 Sillect Ave, Suite 202, Bakersfield, CA 93308-6370
	(661) 324-7300
	(661) 869-2003

Physician's Profile

Full Name	Syed Alam
Gender	Male
Speciality	Pulmonary Disease
Experience	35 Years
Location	2901 Sillect Ave, Bakersfield, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Syed Alam graduated from medical school in 1989

NPI Data:

NPI Number: 1073541512
Provider Enumeration Date: 06/30/2006
Last Update Date: 11/15/2007

Medicare PECOS Information:

PECOS PAC ID: 6002862224
Enrollment ID: I20050330000560

Medical Identifiers

Medical identifiers for Syed Alam such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073541512	NPI	-	NPPES
10939943	Other	CA	CAQH
00A533090	Medicaid	CA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RP1001X	Internal Medicine - Pulmonary Disease	A53309 (California)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Around The Clock Home Care	Bakersfield, CA	Home health agency
Adventist Health Home Care Services	Bakersfield, CA	Home health agency
Bakersfield Memorial Hospital	Bakersfield, CA	Hospital
Adventist Health Bakersfield	Bakersfield, CA	Hospital
Mercy Hospital	Bakersfield, CA	Hospital
Bakersfield Heart Hospital	Bakersfield, CA	Hospital
Ridgecrest Regional Hospital	Ridgecrest, CA	Hospital

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Syed Alam allows following entities to bill medicare on his behalf.

Entity Name	Syed Alam M.d. Pulmonology A Professional Med Corp
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1972726354 PECOS PAC ID: 6103161336 Enrollment ID: O20190215002727

News Archive

FDA issues health advisory on Levemir insulin

The U.S. Food and Drug Administration has learned that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. have reappeared and are being sold in the U.S. market.

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Mundipharma International Limited's network of independent associated companies are launching Remsima® (infliximab) this month in Germany, Italy, UK, Netherlands, Belgium and Luxembourg following expiry of the relevant patents and Supplementary Protection Certificates, having secured distribution rights from Celltrion Healthcare Hungary Kft for Remsima in these markets.

Study reveals new information about origin of tumors

A study by Travis H. Stracker, researcher at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, reveals new information about the origin of tumors.

MRD monitoring falls short in childhood AML assessment

Measuring treatment response by minimal residual disease monitoring offers no more prognostic value than morphologic analysis in children with acute myeloid leukemia (AML), show study findings.

Silicon Valley Bank provides new $10M credit facility to Solta Medical

Silicon Valley Bank, financial partner to technology and life science companies of all sizes worldwide, added a new $10 million term loan to existing credit facilities for Solta Medical, a global leader in the medical aesthetics market. The additional term loan increases Solta Medical's credit facilities with Silicon Valley Bank to a total of $22 million. Solta Medical would expect to use the additional facility to pursue strategic initiatives.

Entity Name	American Compassionate Hospice Care Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1477021244 PECOS PAC ID: 5294073649 Enrollment ID: O20200908000757

FDA issues health advisory on Levemir insulin

The U.S. Food and Drug Administration has learned that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. have reappeared and are being sold in the U.S. market.

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Study reveals new information about origin of tumors

MRD monitoring falls short in childhood AML assessment

Measuring treatment response by minimal residual disease monitoring offers no more prognostic value than morphologic analysis in children with acute myeloid leukemia (AML), show study findings.

Silicon Valley Bank provides new $10M credit facility to Solta Medical

Entity Name	Atlas Urgent Care Corporation
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1568070662 PECOS PAC ID: 2961813670 Enrollment ID: O20210325000329

FDA issues health advisory on Levemir insulin

The U.S. Food and Drug Administration has learned that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. have reappeared and are being sold in the U.S. market.

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Study reveals new information about origin of tumors

MRD monitoring falls short in childhood AML assessment

Measuring treatment response by minimal residual disease monitoring offers no more prognostic value than morphologic analysis in children with acute myeloid leukemia (AML), show study findings.

Silicon Valley Bank provides new $10M credit facility to Solta Medical

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Syed Alam is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Syed Alam, MD Po Box 379, Bakersfield, CA 93302-0379 Ph: (661) 324-7300	Syed Alam, MD 2901 Sillect Ave, Suite 202, Bakersfield, CA 93308-6370 Ph: (661) 324-7300

News Archive

FDA issues health advisory on Levemir insulin

The U.S. Food and Drug Administration has learned that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. have reappeared and are being sold in the U.S. market.

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Study reveals new information about origin of tumors

MRD monitoring falls short in childhood AML assessment

Measuring treatment response by minimal residual disease monitoring offers no more prognostic value than morphologic analysis in children with acute myeloid leukemia (AML), show study findings.

Silicon Valley Bank provides new $10M credit facility to Solta Medical

Internal Medicine Doctors in Bakersfield, CA

Marsha Cheng, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 Wible Rd Ste 14, Bakersfield, CA 93304 Phone: 661-835-1240 Fax: 661-835-4667
Sarah Dowda, NP Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 8327 Brimhall Rd Ste 704, Bakersfield, CA 93312 Phone: 661-829-7677 Fax: 661-679-6920
Peter Alagona Jr., M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 5020 Commerce Dr, Bakersfield, CA 93309 Phone: 661-324-4100 Fax: 661-324-4600
Paramvir Singh Rahal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9802 Stockdale Hwy, Ste 102, Bakersfield, CA 93311 Phone: 661-323-1200 Fax: 661-616-5339
Harieet Singh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2415 Niles St, Bakersfield, CA 93306 Phone: 661-631-1591 Fax: 661-631-1594
Bruce G Dains, PAC Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2701 Chester Ave, Highgrove Medical Center, Bakersfield, CA 93301 Phone: 661-326-1600 Fax: 661-323-2307
Dr. Oscar W. Rico, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 9001 Stockdale Hwy, 28 Hc, Bakersfield, CA 93311 Phone: 661-654-2395

Syed Alam, MD - Medicare Pulmonary Disease in Bakersfield, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Medicare Reassignments

FDA issues health advisory on Levemir insulin

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Study reveals new information about origin of tumors

MRD monitoring falls short in childhood AML assessment

Silicon Valley Bank provides new $10M credit facility to Solta Medical

FDA issues health advisory on Levemir insulin

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Study reveals new information about origin of tumors

MRD monitoring falls short in childhood AML assessment

Silicon Valley Bank provides new $10M credit facility to Solta Medical

FDA issues health advisory on Levemir insulin

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Study reveals new information about origin of tumors

MRD monitoring falls short in childhood AML assessment

Silicon Valley Bank provides new $10M credit facility to Solta Medical

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA issues health advisory on Levemir insulin

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Study reveals new information about origin of tumors

MRD monitoring falls short in childhood AML assessment

Silicon Valley Bank provides new $10M credit facility to Solta Medical

Internal Medicine Doctors in Bakersfield, CA